Oligodendrogliomas retain nuclear expression of ATRX (Liu et al., 2012; Reuss et al., 2015) and lack widespread nuclear p53 staining differentiating them from astrocytomas (Cancer Genome Atlas Research Network, 2015; Suzuki et al., 2015). This evidence concerns the gene TP53 and oligodendroglioma.